Reactivation of Varicella Zoster Virus after Vaccination for SARS-CoV-2

Seven immunocompetent patients aged > 50 years old presented with herpes zoster (HZ) infection in a median of 9 days (range 7–20) after vaccination against SARS-CoV-2. The occurrence of HZ within the time window 1–21 days after vaccination defined for increased risk and the reported T cell-mediat...

Descripción completa

Detalles Bibliográficos
Autores principales: Psichogiou, Mina, Samarkos, Michael, Mikos, Nikolaos, Hatzakis, Angelos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228758/
https://www.ncbi.nlm.nih.gov/pubmed/34205861
http://dx.doi.org/10.3390/vaccines9060572
_version_ 1783712817533157376
author Psichogiou, Mina
Samarkos, Michael
Mikos, Nikolaos
Hatzakis, Angelos
author_facet Psichogiou, Mina
Samarkos, Michael
Mikos, Nikolaos
Hatzakis, Angelos
author_sort Psichogiou, Mina
collection PubMed
description Seven immunocompetent patients aged > 50 years old presented with herpes zoster (HZ) infection in a median of 9 days (range 7–20) after vaccination against SARS-CoV-2. The occurrence of HZ within the time window 1–21 days after vaccination defined for increased risk and the reported T cell-mediated immunity involvement suggest that COVID-19 vaccination is a probable cause of HZ. These cases support the importance of continuing assessment of vaccine safety during the ongoing massive vaccination for the COVID-19 pandemic and encourage reporting and communication of any vaccination-associated adverse event.
format Online
Article
Text
id pubmed-8228758
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-82287582021-06-26 Reactivation of Varicella Zoster Virus after Vaccination for SARS-CoV-2 Psichogiou, Mina Samarkos, Michael Mikos, Nikolaos Hatzakis, Angelos Vaccines (Basel) Article Seven immunocompetent patients aged > 50 years old presented with herpes zoster (HZ) infection in a median of 9 days (range 7–20) after vaccination against SARS-CoV-2. The occurrence of HZ within the time window 1–21 days after vaccination defined for increased risk and the reported T cell-mediated immunity involvement suggest that COVID-19 vaccination is a probable cause of HZ. These cases support the importance of continuing assessment of vaccine safety during the ongoing massive vaccination for the COVID-19 pandemic and encourage reporting and communication of any vaccination-associated adverse event. MDPI 2021-06-01 /pmc/articles/PMC8228758/ /pubmed/34205861 http://dx.doi.org/10.3390/vaccines9060572 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Psichogiou, Mina
Samarkos, Michael
Mikos, Nikolaos
Hatzakis, Angelos
Reactivation of Varicella Zoster Virus after Vaccination for SARS-CoV-2
title Reactivation of Varicella Zoster Virus after Vaccination for SARS-CoV-2
title_full Reactivation of Varicella Zoster Virus after Vaccination for SARS-CoV-2
title_fullStr Reactivation of Varicella Zoster Virus after Vaccination for SARS-CoV-2
title_full_unstemmed Reactivation of Varicella Zoster Virus after Vaccination for SARS-CoV-2
title_short Reactivation of Varicella Zoster Virus after Vaccination for SARS-CoV-2
title_sort reactivation of varicella zoster virus after vaccination for sars-cov-2
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228758/
https://www.ncbi.nlm.nih.gov/pubmed/34205861
http://dx.doi.org/10.3390/vaccines9060572
work_keys_str_mv AT psichogioumina reactivationofvaricellazostervirusaftervaccinationforsarscov2
AT samarkosmichael reactivationofvaricellazostervirusaftervaccinationforsarscov2
AT mikosnikolaos reactivationofvaricellazostervirusaftervaccinationforsarscov2
AT hatzakisangelos reactivationofvaricellazostervirusaftervaccinationforsarscov2

Ejemplares similares